Successful treatment of chronic hepatitis C virus infection with crushed elbasvir/grazoprevir administered through a nasogastric tube in a patient with hypoxic encephalopathy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
The Kaohsiung journal of medical sciences - 38(2022), 1 vom: 19. Jan., Seite 77-78 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chang, Wen-Cheng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4O2AB118LA |
|---|
| Anmerkungen: |
Date Completed 25.03.2022 Date Revised 09.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/kjm2.12455 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331004984 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331004984 | ||
| 003 | DE-627 | ||
| 005 | 20231225212519.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/kjm2.12455 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1103.xml |
| 035 | |a (DE-627)NLM331004984 | ||
| 035 | |a (NLM)34558811 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chang, Wen-Cheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successful treatment of chronic hepatitis C virus infection with crushed elbasvir/grazoprevir administered through a nasogastric tube in a patient with hypoxic encephalopathy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2022 | ||
| 500 | |a Date Revised 09.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Amides |2 NLM | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Benzofurans |2 NLM | |
| 650 | 7 | |a Carbamates |2 NLM | |
| 650 | 7 | |a Cyclopropanes |2 NLM | |
| 650 | 7 | |a Imidazoles |2 NLM | |
| 650 | 7 | |a Quinoxalines |2 NLM | |
| 650 | 7 | |a Sulfonamides |2 NLM | |
| 650 | 7 | |a grazoprevir |2 NLM | |
| 650 | 7 | |a 4O2AB118LA |2 NLM | |
| 650 | 7 | |a elbasvir |2 NLM | |
| 650 | 7 | |a 632L571YDK |2 NLM | |
| 700 | 1 | |a Chen, Hsuan-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Hsieh, Tsai-Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Jung-Chun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Kaohsiung journal of medical sciences |d 1996 |g 38(2022), 1 vom: 19. Jan., Seite 77-78 |w (DE-627)NLM086492993 |x 2410-8650 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2022 |g number:1 |g day:19 |g month:01 |g pages:77-78 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/kjm2.12455 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2022 |e 1 |b 19 |c 01 |h 77-78 | ||